New Avenues of Asthma Therapy

Abstract

Get full access to this article

View all access options for this article.

References

Barnes

. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517–1527.

Cockcroft

. Therapy for airway inflammation in asthma. J Allergy Clin Immunol 1991;87:914–919.

Feldberg

, Kellaway

. Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol (Cambridge) 1938;94:187–226.

Samuelsson

Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568–575.

Drazen

, Austen

. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:985–998.

Page

. Mechanisms of hyperresponsiveness: platelet activating factor. Am Rev Respir Dis 1992;145:S31–S33.

Alabaster

, Moore

. Drug intervention in asthma: present and future. Thorax 1993;48:176–182.

Szefler

. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991;88:147–165.

Geddes

. Inhaled corticosteroids: benefits and risks. Thorax 1992;47:404–407.

10.

Toogood

. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990;141:S89–S96.

11.

Chanarin

, Johnston

. Leukotrienes as a target in asthma therapy. Drugs 1994;47:12–24.

12.

Barnes

, Piper

, Costello

. Comparative effects of inhaled leukotriene C4, leuktriene D4, and histamine in normal human subjects. Thorax 1984;39:500–504.

13.

Piacentini

, Kaliner

. The potential roles of leukotrienes in bronchial asthma. Am Rev Respir Dis 1991;143:S96–S99.

14.

Marom

, Shelhamer

, Bach

, Morton DR , Kaliner

. Slow reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways. Am Rev Respir Dis 1982;126:449–451.

15.

Sampson

, Thomas

, Costello

, Piper

. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Brit J Pharmacol 1992;33:423–430.

16.

Lam

, Chan

, LeRiche

, Chan-Yeung

, Salari

Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711–717.

17.

Lee

, Walport

, Wilkinson

, Turner-Warwick

, Kay

. Slow reacting substances of anaphylaxis antagonist FPL-55712 in chronic asthma. Lancet 1981;2:304–305.

18.

Hutchinson

. personal communication, quoted in Reference 11:20 1994.

19.

Cloud

, Enas

, Kemp

, Platt-Mills

, Altman

, Townley

, . A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis 1989;140:1336–1339.

20.

Margolskee

, Bodman

, Dockhorn

, Israel

, Kemp

, Mansmann

, . The therapeutic effects of MK-571, a potent and selective leukotriene D4 receptor antagonist, in patients with chronic asthma (abstract). J Allergy Clin Immunol 1991;87:309.

21.

Hui

, Barnes

. Lung function improvement in asthma with a cysteinyl leukotriene receptor antagonist. Lancet 1991;337:1062–1063.

22.

Spector

, Glass

, Minkwitz

, ICI Asthma Trial Group. The effect of six weeks of therapy with oral doses of ICI-204, 219 in asthmatics (abstract). Am Rev Respir Dis 1992;145(4, part 2):A16.

23.

Drazen

. personal communication, quoted in Reference 11:20 1994.

24.

Barnes

, Chung

, Page

. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988;81:919–934.

25.

Braquet

, Touqui

, Shen

, Vargaftig

. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97–145.

26.

Wilkens

, Wilkens

, Bosse

, Kempe

, Fritz

, Frohlich

, Fabel

Effects of an inhaled PAF-antagonist (WEB-2068 BS) on allergen-induced early and late asthmatic responses and increased bronchial responsiveness to methacholine (abstract). Am Rev Respir Dis 1991;143(4, part 2):A812.

27.

Freitag

, Watson

, Matsog

, Eastwood

, O'Byrne

. The effect of treatment with an oral platelet activating factor antagonist (WEB-2086) on allergen-induced asthmatic responses in human subjects (abstract). Am Rev Respir Dis 1991;143(4, part 2):A157.

28.

Bel

, DeSmet

, Rossing

, Timmers

, Dijkman

, Sterk

. The effect of a specific oral PAF antagonist, MK-287 on antigen-induced early and late asthmatic reactions in man (abstract). Am Rev Respir Dis 1991;143(4, part 2):A811.

29.

Kuitert

, Hui

, Uthayarkumar

, Burke

, Newland

, Uden

, Barnes

. Effect of a platelet activating factor (PAF) antagonist UK-74,505 on allergen-induced early and late response (abstract). Am Rev Respir Dis 1992;145(4, part 2):A292.

30.

Gardiner

. Prostanoid agonists/inhibitors. In: Barnes PJ, ed. New drugs for asthma, vol 2. London: International Business Communications, 1992:68–77.

31.

Iwamoto

, Ra

, Sato

, Tomioka

, Yoshida

Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. J Asthma 1988;215:117–124.

32.

Schleimer

, Sterbinsky

, Kaiser

, Bickel

, Klunk

, Tomioka

, . Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086–1092.

33.

Loh

RKS

, Jabara

, Geha

. Cromolyn sodium and nedocromil sodium inhibit deletional switch recombination and IgE synthesis in human B cells (abstract). J Allergy Clin Immunol 1994;93:219.

34.

Iwama

, Nagai

, Suda

, Tsuruoka

, Koda

Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways (abstract). Brit J Pharmacol 1992;105:19.

35.

Nicholson

, Shahid

Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes their potential utility in the therapy of asthma. Pulm Pharmacol 1994;7:1–17.

36.

Duplantier

, Cheng

. Emerging opportunities in the treatment of asthma and allergy. Ann Rep Medicinal Chem 1994;29:73–81.